A paper published in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel ...

Apnimed, a startup in Cambridge, this month reported positive test results for a pill - form medication to treat sleep apnea. If approved by federal regulators, it would become the first pill to treat ...

The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans ...

In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.

Does a Cambridge startup have a pill that can treat sleep apnea? Last week, Apnimed, a little-known pharma startup founded in 2017, announced encouraging results from its clinical trial of a new drug ...

Pill penalty disincentivizes R&D At a superficial level this results in somewhat lower drug prices, but it disincentivizes ...

The first human-tested weight-loss drug that burns calories through creatine-based heat generation, without reducing appetite ...

Can nature help us heal faster? Dr. Jay Maddock explains how biophilic design is transforming hospitals and boosting patient recovery.

The new study, "Compositional Flows for 3D Molecule and Synthesis Pathway Co-design", i ntroduces an innovative method, called CGFlow, that tackles one of the pharmaceutical industry’s most persistent ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to know ...

This research could represent the first documented case of paracetamol production from plastic waste using E. coli bacteria.